Psoriatic arthritis (PsA), a chronic inflammatory arthritis, affects about 10% of patients with
psoriasis with higher prevalence seen in patients with more extensive skin disease. Early …

Objective To estimate the incidence of psoriatic arthritis (PsA) in patients with psoriasis, and
to identify risk factors for its development. Methods The study was designed as a prospective …

Background Wide-ranging prevalence estimates of psoriatic arthritis (PsA) in patients with
psoriasis have been reported. Objectives To assess the prevalence and incidence of PsA in …

Psoriatic arthritis (PsA) is a chronic, progressive musculoskeletal disease that affects 0.1%–
1% of the general population and~ 20% of patients with psoriasis. Significant differences …

Objective To determine the incidence and disease‐specific predictors of clinically
recognized psoriatic arthritis (PsA) in patients with psoriasis. Methods We identified an …

Background Agreement on how to identify psoriasis (PsO) patients at risk of developing
psoriatic arthritis (PsA) is lacking. Objective To identify predictors, risk factors and incidence …

Background The characteristics that predict the onset of psoriatic arthritis (PsA) among
patients with psoriasis (PsO) may inform diagnosis and treatment. Objective To develop a …

It is unclear whether psoriasis is a progressive disease that requires early aggressive
intervention. This population-based study identified patients with psoriasis and psoriatic …

Objective Epidemiologic studies about the incidence of psoriatic arthritis (PsA) are limited to
a few population‐based studies. There are limited data regarding the incidence of PsA in …

PSORIATIC ARTHRITIS (PSA) IS A CHRONIC IN-flammatory disease that can be
progressive and may be associated with permanent joint damage and disability. Though …